Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
11.0 MIU IL-2 per day[1] Human interleukin-2 (IL-2)---[1] 2 💬
22.0 MIU IL-2 per day[1] Human interleukin-2 (IL-2)---[1] 2 💬
3Anti-IL-20[1] Fletikumab (Anti-IL-20)[1] Fletikumab 💬 [1] IL20 💬 [3] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
4Anti-IL-20 (109-0012)[1] Fletikumab (Anti-IL-20)[1] Fletikumab 💬 [1] IL20 💬 [3] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
5Anti-IL-23 monoclonal antibody----[1] 96 💬
6Anticorpo monoclonale anti IL-23----[1] 96 💬
7Anticorpo monoclonale anti-IL-23----[1] 96 💬
8IL-2[1] Human interleukin-2 (IL-2)---[5] 2, 46, 49, 53, 56 💬
9IL-22Fc[1] Efmarodocokin alfa (IL-22Fc)[1] Efmarodocokin alfa 💬 [1] IL22 💬 [4] Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬[2] 96, 97 💬
10Low-dose IL-2[1] Human interleukin-2 (IL-2)---[1] 56 💬
11Recombinant human anti IL-22 monoclonal antibody IgG1----[1] 46 💬
12TYF-IL-2Rg gene-modified autologous stem cells----[1] 65 💬
13UTTR1147A, IL22-Fc, IL-22Fc[1] Efmarodocokin alfa (IL-22Fc)[1] Efmarodocokin alfa 💬 [1] IL22 💬 [4] Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬[2] 96, 97 💬